Full Text | PDF

Theranostics 2024; 14(6):2637-2655. doi:10.7150/thno.93322 This issue Cite

Research Paper

Size control of ropivacaine nano/micro-particles by soft-coating with peptide nanosheets for long-acting analgesia

Jing Liu^1,2, Weiwei Wu^1,2, Fei Peng^1,2, Deying Gong^1,2, Yi Kang^1,2, Yujun Zhang^1,2, Congyan Liu², Yuncheng Li², Guoyan Zhao², Feng Qiu^1,2,✉, Wensheng Zhang^1,2,✉

1. Department of Anesthesiology, West China Hospital, Sichuan University, China.
2. Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, China.

✉ Corresponding authors: E-mails: fengqiuedu.cn, zhang_wsedu.cn.

Abstract

Rationale: To meet the need of long-acting analgesia in postoperative pain management, slow-releasing formulations of local anesthetics (LAs) have been extensively investigated. However, challenges still remain in obtaining such formulations in a facile and cost-effective way, and a mechanism for controlling the release rate to achieve an optimal duration is still missing.

Methods: In this study, nanosheets formed by a self-assembling peptide were used to encapsulate ropivacaine in a soft-coating manner. By adjusting the ratio between the peptide and ropivacaine, ropivacaine particles with different size were prepared. Releasing profile of particles with different size were studied in vitro and in vivo. The influence of particle size and ropivacaine concentration on effective duration and toxicity were evaluated in rat models.

Results: Our results showed that drug release rate became slower as the particle size increased, with particles of medium size (2.96 ± 0.04 μm) exhibiting a moderate release rate and generating an optimal anesthetic duration. Based on this size, formulations at different ropivacaine concentrations generated anesthetic effect with different durations in rat sciatic nerve block model, with the 6% formulation generated anesthetic duration of over 35 h. Long-acting analgesia up to 48 h of this formulation was also confirmed in a rat total knee arthroplasty model.

Conclusion: This study provided a facile strategy to prepare LA particles of different size and revealed the relationship between particle size, release rate and anesthetic duration, which provided both technical and theoretical supports for developing long-acting LA formulations with promising clinical application.

Keywords: long-acting analgesia, particle size, ropivacaine, slow-release, self-assembling peptides

Citation styles

©2024 Ivyspring International Publisher. Terms of use